Biomarkers in breast cancer: IQWiG criticizes conclusion on MINDACT data in US guideline

(Institute for Quality and Efficiency in Health Care) In their updated guideline, US oncologists recently recommended the MammaPrint test. Researchers from IQWiG have reacted in a letter to the editor in the Journal of Clinical Oncology.